A novel immunoglobulin A nephropathy (IgAN) drug cut proteinuria in half, according to interim findings from the ongoing ...

AstraZeneca targets $80bn revenue by 2030, driven by oncology and new drugs, but faces patent risks and tough competition.

TEM is a data-rich platform that recently clinched a $200 million deal with AstraZeneca. TEM’s main bet is now on AI for ...

COVID-19 cases rise in India with mild symptoms, no need for mass vaccination, focus on preventive measures emphasized.

Only 25% of AI projects meet ROI goals. IBM argues the solution is strategy-first, not more hype. Learn how to scale AI with ...

EU approves AstraZeneca’s Calquence in combo with venetoclax, with or without obinutuzumab to treat adult patients with previously untreated CLL: Cambridge, UK Saturday, June 7, ...

President Donald J. Trump just released his second executive order (EO) addressing high prescription drug prices. This is ...

More than 240,000 people have signed a petition to ban dog testing ...

In the week ending June 6, 2025, the Indian equity markets posted significant gains, bolstered by a surprise 50 basis points ...

Snapping two week losing Streak Sensex surged 737.98 points or 0.90 per cent to settle at 82,188.99 during the week ended ...

The global populating is aging, and approximately 29% of people with diabetes worldwide are aged 65 years and older, ...